• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植物雌激素和内分泌干扰物对乳腺癌细胞的外源性激素调节。

Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.

机构信息

Universita degli Studi dell'Insubria, Facolta di Medicina e Chirurgia, Dipartimento di Biotecnologie e Scienze della Vita, Viale Dunant, n.3 Varese, Italy, 21100.

出版信息

Curr Med Chem. 2014;21(9):1129-45. doi: 10.2174/09298673113206660291.

DOI:10.2174/09298673113206660291
PMID:24304271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4153070/
Abstract

Observations on the role of ovarian hormones in breast cancer growth, as well as interest in contraception, stimulated research into the biology of estrogens. The identification of the classical receptors ERα and ERβ and the transmembrane receptor GPER and the resolution of the structure of the ligand bound to its receptor established the principal molecular mechanisms of estrogen action. The presence of estrogen-like compounds in many plants used in traditional medicine or ingested as food ingredients, phytoestrogens, as well as the estrogenic activities of many industrial pollutants and pesticides, xenoestrogens, have prompted investigations into their role in human health. Phyto- and xenoestrogens bind to the estrogen receptors with a lower affinity than the endogenous estrogens and can compete or substitute the hormone. Xenoestrogens, which accumulate in the body throughout life, are believed to increase breast cancer risk, especially in cases of prenatal and prepuberal exposure whereas the role of phytoestrogens is still a matter of debate. At present, the application of phytoestrogens appears to be limited to the treatment of post-menopausal symptoms in women where the production of endogenous estrogens has ceased. In this review we discuss chemistry, structure and classification, estrogen signaling and the consequences of the interactions of estrogens, phytoestrogens and xenoestrogens with their receptors, the complex interactions of endogenous and exogenous ligands, the evaluation of the health risks related to xenoestrogens, and the perspectives toward the synthesis of potent third generation selective estrogen receptor modulators (SERMs).

摘要

对卵巢激素在乳腺癌生长中的作用的观察,以及对避孕的关注,激发了对雌激素生物学的研究。经典受体 ERα 和 ERβ 以及跨膜受体 GPER 的鉴定,以及配体与其受体结合的结构的解析,确立了雌激素作用的主要分子机制。许多传统医学中使用的植物或作为食物成分摄入的植物中存在类雌激素化合物,植物雌激素,以及许多工业污染物和农药的雌激素活性,异雌激素,促使人们研究它们在人类健康中的作用。植物雌激素和异雌激素与雌激素受体的结合亲和力低于内源性雌激素,并且可以竞争或替代激素。异雌激素在整个生命过程中在体内积累,被认为会增加乳腺癌的风险,特别是在产前和青春期暴露的情况下,而植物雌激素的作用仍然存在争议。目前,植物雌激素的应用似乎仅限于治疗已经停止产生内源性雌激素的绝经后妇女的症状。在这篇综述中,我们讨论了化学、结构和分类、雌激素信号转导以及雌激素、植物雌激素和异雌激素与其受体相互作用的后果,内源性和外源性配体的复杂相互作用,与异雌激素相关的健康风险的评估,以及对合成有效第三代选择性雌激素受体调节剂 (SERM) 的展望。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/8cf9c2c516d1/CMC-21-1129_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/8e6a8377c797/CMC-21-1129_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/b131d8716ce1/CMC-21-1129_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/a29d2372ac52/CMC-21-1129_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/8cf9c2c516d1/CMC-21-1129_F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/8e6a8377c797/CMC-21-1129_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/b131d8716ce1/CMC-21-1129_F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/a29d2372ac52/CMC-21-1129_F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82ed/4153070/8cf9c2c516d1/CMC-21-1129_F4.jpg

相似文献

1
Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.植物雌激素和内分泌干扰物对乳腺癌细胞的外源性激素调节。
Curr Med Chem. 2014;21(9):1129-45. doi: 10.2174/09298673113206660291.
2
Hormonal action of plant derived and anthropogenic non-steroidal estrogenic compounds: phytoestrogens and xenoestrogens.植物源和人为非甾体类雌激素化合物的激素作用:植物雌激素和外源性雌激素。
Curr Med Chem. 2010;17(30):3542-74. doi: 10.2174/092986710792927813.
3
Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling.植物雌激素通过 GPER-1/GPR30 信号通路在乳腺癌中的可能作用。
Clin Sci (Lond). 2018 Dec 13;132(24):2583-2598. doi: 10.1042/CS20180885. Print 2018 Dec 21.
4
Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture.天然及合成雌激素在培养的人乳腺癌细胞中的雌激素活性。
Environ Health Perspect. 1997 Apr;105 Suppl 3(Suppl 3):637-45. doi: 10.1289/ehp.97105s3637.
5
Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.选定的外源性和内源性雌激素的药代动力学和毒代动力学:数据综述及知识空白识别
Crit Rev Toxicol. 2014 Sep;44(8):696-724. doi: 10.3109/10408444.2014.930813. Epub 2014 Aug 6.
6
Interactions of isoflavones and other plant derived estrogens with estrogen receptors for prevention and treatment of breast cancer-considerations concerning related efficacy and safety.异黄酮和其他植物雌激素与雌激素受体的相互作用,用于预防和治疗乳腺癌-关于相关疗效和安全性的考虑。
J Steroid Biochem Mol Biol. 2014 Jan;139:237-44. doi: 10.1016/j.jsbmb.2012.12.010. Epub 2012 Dec 27.
7
Metabolism and health effects of phyto-estrogens.植物雌激素的代谢与健康影响。
Crit Rev Food Sci Nutr. 2017 Jul 24;57(11):2432-2454. doi: 10.1080/10408398.2015.1077194.
8
Phytoestrogens, novel dietary supplements for breast cancer.植物雌激素,乳腺癌的新型膳食补充剂。
Biomed Pharmacother. 2023 Apr;160:114341. doi: 10.1016/j.biopha.2023.114341. Epub 2023 Feb 6.
9
Phytoestrogens and breast cancer: In vitro anticancer activities of isoflavones, lignans, coumestans, stilbenes and their analogs and derivatives.植物雌激素与乳腺癌:异黄酮、木脂素、香豆素、芪类及其类似物和衍生物的体外抗癌活性。
Biomed Pharmacother. 2018 Nov;107:1648-1666. doi: 10.1016/j.biopha.2018.08.100. Epub 2018 Sep 8.
10
Exploring the Biological Activity and Mechanism of Xenoestrogens and Phytoestrogens in Cancers: Emerging Methods and Concepts.探讨外源性雌激素和植物雌激素在癌症中的生物学活性和作用机制:新兴方法和概念。
Int J Mol Sci. 2021 Aug 16;22(16):8798. doi: 10.3390/ijms22168798.

引用本文的文献

1
Screening of Optimal Phytoconstituents through Docking, Toxicity, Pharmacokinetic, and Molecular Dynamics Approach for Fighting against Polycystic Ovarian Syndrome.通过对接、毒性、药代动力学和分子动力学方法筛选对抗多囊卵巢综合征的最佳植物成分
Curr Pharm Des. 2025;31(26):2085-2104. doi: 10.2174/0113816128330398241015115043.
2
A Compressive Review on Source, Toxicity and Biological Activity of Flavonoid.黄酮类化合物的来源、毒性及生物活性的综合评述
Curr Top Med Chem. 2024;24(24):2093-2116. doi: 10.2174/0115680266316032240718050055.
3
Estrogenic Activity and Risk of Invasive Breast Cancer Among Postmenopausal Women in the Nurses' Health Study.

本文引用的文献

1
On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases.论乳癌不可手术病例的治疗:一种新治疗方法的建议及实例说明
Trans Med Chir Soc Edinb. 1896;15:153-179.
2
Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells.内分泌干扰物壬基酚对雌激素受体阳性乳腺癌细胞具有雌激素样转录活性。
Curr Med Chem. 2014;21(5):630-40. doi: 10.2174/09298673113209990169.
3
Breast cancer and flavonoids - a role in prevention.
绝经后妇女中雌激素活性与浸润性乳腺癌风险的关系。在护士健康研究中。
Cancer Epidemiol Biomarkers Prev. 2022 Apr 1;31(4):831-838. doi: 10.1158/1055-9965.EPI-21-1157.
4
Immunomodulation of carcinogens-induced steroids-dependent human diseases.致癌物诱导的类固醇依赖性人类疾病的免疫调节
Saudi J Biol Sci. 2019 Feb;26(2):244-251. doi: 10.1016/j.sjbs.2017.09.014. Epub 2017 Oct 3.
5
Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERα) by various parameters and molecular modelling approach.通过各种参数和分子建模方法测定和分析天然类黄酮对雌激素受体(ERα)的激动剂和拮抗剂潜力。
Sci Rep. 2019 May 15;9(1):7450. doi: 10.1038/s41598-019-43768-5.
6
Identification of Sex-Specific Transcriptome Responses to Polychlorinated Biphenyls (PCBs).鉴定多氯联苯(PCBs)对性别特异性转录组的响应。
Sci Rep. 2019 Jan 24;9(1):746. doi: 10.1038/s41598-018-37449-y.
7
Risk of lymphoma subtypes by occupational exposure in Southern Italy.意大利南部职业暴露导致的淋巴瘤亚型风险。
J Occup Med Toxicol. 2017 Nov 23;12:31. doi: 10.1186/s12995-017-0177-2. eCollection 2017.
8
Polyphenols as Promising Drugs against Main Breast Cancer Signatures.多酚有望成为对抗主要乳腺癌特征的药物。
Antioxidants (Basel). 2017 Nov 7;6(4):88. doi: 10.3390/antiox6040088.
9
Simple assay for screening phytoestrogenic compounds using the oestrogen receptor immobilised magnetite nanoparticles.使用固定有雌激素受体的磁铁矿纳米颗粒筛选植物雌激素化合物的简易测定法。
IET Nanobiotechnol. 2017 Jun;11(4):395-402. doi: 10.1049/iet-nbt.2016.0139.
10
Postmenopausal Breast Cancer Risk in Relation to Antibodies Specific to Benzo[a]Pyrene, Estradiol and Progesterone.绝经后乳腺癌风险与苯并[a]芘、雌二醇和孕酮特异性抗体的关系
Iran J Cancer Prev. 2016 Apr 24;9(2):e4212. doi: 10.17795/ijcp-4212. eCollection 2016 Apr.
乳腺癌与黄酮类化合物——预防作用
Curr Pharm Des. 2013;19(34):6125-32. doi: 10.2174/1381612811319340006.
4
The influence of endocrine disruptors in a selected population of infertile women.内分泌干扰物对特定不孕人群的影响。
Gynecol Endocrinol. 2013 May;29(5):444-7. doi: 10.3109/09513590.2012.758702. Epub 2013 Jan 24.
5
The pros and cons of plant estrogens for menopause.植物雌激素对更年期的利弊。
J Steroid Biochem Mol Biol. 2014 Jan;139:225-36. doi: 10.1016/j.jsbmb.2012.12.004. Epub 2012 Dec 25.
6
The influence of endocrine disruptors on growth and development of children.内分泌干扰物对儿童生长发育的影响。
Curr Opin Endocrinol Diabetes Obes. 2013 Feb;20(1):50-5. doi: 10.1097/MED.0b013e32835b7ee6.
7
Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms.综述:内分泌干扰化学物质与免疫应答:以双酚 A 为例及其潜在机制
Mol Immunol. 2013 Apr;53(4):421-30. doi: 10.1016/j.molimm.2012.09.013. Epub 2012 Oct 31.
8
Recent advances in the rationale design of GPER ligands.近期 GPER 配体合理设计的进展。
Curr Med Chem. 2012;19(36):6199-206.
9
Toxicologically relevant phthalates in food.食品中具有毒理学相关性的邻苯二甲酸盐。
Exp Suppl. 2012;101:87-106. doi: 10.1007/978-3-7643-8340-4_4.
10
Current concepts and significance of estrogen receptor β in prostate cancer.当前前列腺癌中雌激素受体 β 的概念和意义。
Steroids. 2012 Oct;77(12):1262-6. doi: 10.1016/j.steroids.2012.07.002. Epub 2012 Jul 20.